NBIX
Neurocrine Biosciences·NASDAQ
--
--(--)
--
--(--)
4.59 / 10
Netural
Technical rating is neutral (4.59/10). A MACD golden cross scores 7.6, indicating bullish momentum, but a bearish Marubozu white pattern (1.6) and a modest MACD death cross (4.6) offset gains. Market direction remains unclear.
Analysis Checks(1/3)
MACD Death Cross
Score4.58/10
Win Rate55.56%
Hist. Signals9
Avg Return0.09%
Score4.58/10
Win Rate55.56%
Hist. Signals9
Avg Return0.09%
Marubozu White
Score1.56/10
Win Rate40.00%
Hist. Signals15
Avg Return-0.88%
Score1.56/10
Win Rate40.00%
Hist. Signals15
Avg Return-0.88%
MACD Golden Cross
Score7.64/10
Win Rate77.78%
Hist. Signals9
Avg Return0.68%
Score7.64/10
Win Rate77.78%
Hist. Signals9
Avg Return0.68%
MACD Death Cross
Score4.58/10
Win Rate55.56%
Hist. Signals9
Avg Return0.09%
Score4.58/10
Win Rate55.56%
Hist. Signals9
Avg Return0.09%
MACD Golden Cross
Score7.64/10
Win Rate77.78%
Hist. Signals9
Avg Return0.68%
Score7.64/10
Win Rate77.78%
Hist. Signals9
Avg Return0.68%
Marubozu White
Score1.56/10
Win Rate40.00%
Hist. Signals15
Avg Return-0.88%
Score1.56/10
Win Rate40.00%
Hist. Signals15
Avg Return-0.88%
What is the current technical signals for NBIX?
- NBIX presents a Netural setup with a Technical Score of 4.59/10. Key technical indicators highlight an RSI of 54.72 and a MACD of 0.98, with the trend anchored by the 50-Day SMA at 132.00. Traders should monitor key support at 129.81 and resistance at 133.83.
